Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
AMSBIO (Oxford, UK) announces an innovative range of induced pluripotent stem cell (iPSC) kits for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback